Proton (1H) MR spectroscopy of the breast Journal Article


Authors: Bartella, L.; Huang, W.
Article Title: Proton (1H) MR spectroscopy of the breast
Abstract: Proton (hydrogen 1) [1H]) magnetic resonance (MR) spectroscopy provides biochemical information about the tissue under investigation. Its diagnostic value in cancer is typically based on the detection of elevated levels of choline compounds, choline being a marker of active tumor. The two main potential clinical applications of 1H MR spectroscopy are (a) as an adjunct to breast MR imaging to improve specificity in differentiating benign from malignant lesions, and (b) for monitoring or even predicting response to treatment in patients undergoing neoadjuvant chemotherapy. Preliminary data are promising, with study results suggesting that 1H MR spectroscopy may decrease the number of benign biopsies recommended on the basis of MR imaging findings and may help predict response as early as 24 hours after the first dose of neoadjuvant chemotherapy. Although several limitations currently exist that make the technique premature for clinical use, further evaluation with larger, preferably multicenter trials is certainly warranted. ©RSNA, 2007.
Keywords: adult; aged; middle aged; review; breast neoplasms; diagnostic agent; breast tumor; magnetic resonance spectroscopy; nuclear magnetic resonance spectroscopy; protons; breast diseases; breast disease; proton
Journal Title: RadioGraphics
Volume: 27
Issue: Suppl. 1
ISSN: 0271-5333
Publisher: Radiological Society of North America, Inc.  
Date Published: 2007-10-01
Start Page: S241
End Page: S252
Language: English
DOI: 10.1148/rg.27si075504
PUBMED: 18180230
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 11" - "Export Date: 17 November 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wei Huang
    24 Huang